stella
beta
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia — Stella
Recruiting
Back to Acute Leukemia of Ambiguous Lineage trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(107 sites)
United States
Children's Hospital of Alabama, Birmingham, Alabama
Providence Alaska Medical Center, Anchorage, Alaska
Banner Children's at Desert, Mesa, Arizona
Arkansas Children's Hospital, Little Rock, Arkansas
Loma Linda University Medical Center, Loma Linda, California
Show all 107 locations
View full record on ClinicalTrials.gov
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow